A new study out of Italy, entitled “Perfluoroalkyl Substances Are Associated With Elevated Blood Pressure and Hypertension in Highly Exposed Young Adults“, examines incidences of high blood pressure and hypertension in 16,224 individuals ages 20-39 years old who also showed levels of PFAS in blood serum. The study specifically attempts to target drinking water as a potential source of PFAS exposure for the cohort members. Among the PFAS tested for, PFOA was detected at the highest level in the cohorts, followed by PFOS, PFHxS and PFNA. Males showed higher levels of PFAS as compared to females.
The study concluded that their results showed a positive correlation between PFAS concentrations and blood pressure levels, and a “raised prevalance” of hypertension in men only. However, the study also conceded that literature that exists studying the same topic (albeit with different cohort members) is “relatively limited with contradictory findings.” The article also concludes by cautioning that the change in blood pressure found in the cohorts was “quite modest.” The authors also indicate that their findings should be confirmed by further studies, specifically longitudinal studies.
The article, while benefiting from a large cohort group, has admitted shortcomings that need further correlation. Nevertheless, it adds to the growing scientific literature that attempts to examine possible adverse health effects from PFAS.
CMBG3 Law is following judicial, legislative, and administrative developments relating to PFAS. More information about the services we can provide, including risk assessments, to ensure your business is ready for any intersection with these substances can be found on our PFAS Litigation page.
Our attorneys have been at the forefront of PFAS issues, including giving presentations as to the future waves of litigation stemming from PFAS issues. For more information, please contact any of our PFAS – Toxic Torts Team: Jessica Deyoe, Suzanne Englot, Alexandra Fraher,or John Gardella.